Receiveable Turnover: An accounting measure used to quantify a firm's effectiveness in extending credit as well as collecting debts. Calculated as: Total Revenues / Accounts Receivable
COSCIENS Biopharma Inc. (CSCIF) had Receiveable Turnover of 1.40 for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
$1.77M |
|
$-2.18M |
|
$1.16M |
|
$0.61M |
|
$3.91M |
|
$-2.15M |
|
$-0.03M |
|
$-2.17M |
|
$-1.93M |
|
$-2.19M |
|
$-2.18M |
|
$-2.18M |
|
$-1.95M |
|
$-2.15M |
|
$-1.86M |
|
3.17M |
|
3.17M |
|
$-0.69 |
|
$-0.69 |
|
| Balance Sheet Financials | |
$11.50M |
|
$9.81M |
|
$9.93M |
|
$21.43M |
|
$3.61M |
|
-- |
|
$13.98M |
|
$17.59M |
|
$3.84M |
|
$3.84M |
|
$3.84M |
|
3.18M |
|
| Cash Flow Statement Financials | |
$-8.47M |
|
$-0.46M |
|
$-0.41M |
|
$16.39M |
|
$7.31M |
|
$-9.09M |
|
$-0.01M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.18 |
|
-- |
|
-- |
|
-- |
|
-- |
|
34.48% |
|
-121.63% |
|
-121.63% |
|
-- |
|
-123.10% |
|
-123.61% |
|
$-8.94M |
|
-- |
|
-- |
|
-- |
|
0.08 |
|
0.89 |
|
|
Receiveable Turnover |
1.40 |
64.26 |
|
-56.82% |
|
-56.82% |
|
-10.19% |
|
-56.82% |
|
$1.21 |
|
$-2.82 |
|
$-2.68 |
|